Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.5610
-0.0209 (-3.59%)
Apr 9, 2026, 4:00 PM EDT - Market closed
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $12.29 million as of April 9, 2026. Its market cap has decreased by -5.77% in one year.
Market Cap
12.29M
Enterprise Value
7.97M
1-Year Change
-5.77%
Ranking
Category
Stock Price
$0.56
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $12.29M, a decrease of -63.19%. That is a compound annual growth rate of -47.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 12.46M | -15.72% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Intensity Therapeutics | 13.34M |
| GT Biopharma | 13.04M |
| BioCardia | 13.02M |
| Moleculin Biotech | 12.86M |
| Traws Pharma | 12.79M |
| Jupiter Neurosciences | 12.70M |
| Genprex | 12.39M |
| Imunon | 12.24M |